MECP2 and neoplasm: The host pathways enriched among CRC-specific associations are known to modulate tumour growth, progression and metastasis in CRC, such as interleukin-10 signalling, signalling by NOTCH1 in cancer, and regulation of MECP2 expression and activity51–53.